Analyst Ranking
Top 22%
#1056 out of 4995 analysts
Average Return
+9.64%
Win Rate
58%18 out of 31
Risk vs Reward
Poor
Good

Subbu Nambi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Natera IncNTRA
+176.34%$60.27$166.55
2023-12-13 -
2024-12-13
Strong Buy
Guardant Health IncGH
+76.11%$28.88$50.86
2024-06-27 -
2025-06-27
Strong Buy
Tempus Ai IncTEM
+73.16%$46.50$80.52
2024-12-08 -
2025-08-22
Strong Buy
Cryoport IncCYRX
+59.89%$5.61$8.97
2025-04-15 -
2025-08-22
Strong Buy
Guardant Health IncGH
+44.67%$42.44$61.40
2025-02-23 -
2025-08-22
Strong Buy

Subbu Nambi Analyst Color

Get additional color on Subbu Nambi's coverage of popular stocks

Subbu Nambi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Caris Life Sciences IncCAI
2Strong Buy$36.00-8.40%Maintains
12 days ago
Danaher CorpDHR
2Strong Buy$250.00+18.04%Reiterates
a month ago
Genedx Holdings CorpWGS
1Strong Buy$115.00-10.62%Maintains
2 months ago
Tempus Ai IncTEM
2Strong Buy$75.00-6.86%Maintains
2 months ago
Neogen CorpNEOG
3Strong Buy$10.00+77.30%Maintains
2 months ago
Illumina IncILMN
3Strong Buy$114.00+11.98%Maintains
4 months ago
Twist Bioscience CorpTWST
2Strong Buy$50.00+74.89%Reiterates
4 months ago
Cryoport IncCYRX
1Strong Buy$10.00+11.48%Reiterates
4 months ago
Exact Sciences CorpEXAS
2Strong Buy$60.00+26.40%Reiterates
4 months ago
Veracyte IncVCYT
3Strong Buy$37.00+19.35%Maintains
5 months ago
Guardant Health IncGH
2Strong Buy$56.00-8.79%Reiterates
6 months ago
Natera IncNTRA
2Strong Buy$200.00+20.77%Maintains
7 months ago
Bruker CorpBRKR
1Strong Buy$72.00+102.59%Initiates Coverage On
8 months ago
Sophia Genetics SaSOPH
1Strong Buy$6.00N/AInitiates Coverage On
a year ago
Nautilus Biotechnology IncNAUT
1Strong Buy$6.00N/AInitiates Coverage On
a year ago
Castle Biosciences IncCSTL
1Strong Buy$25.00N/AInitiates Coverage On
2 years ago
Myriad Genetics IncMYGN
1Strong Buy$23.00N/AInitiates Coverage On
2 years ago
10x Genomics IncTXG
1Strong Buy$60.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.